Lianhua Qingwen capsules, a patented traditional Chinese medicine popular nationwide against the coronavirus, was recently selected as part of a home-based treatment for people with mild symptoms in Cambodia.

The capsules were licensed in April by the country's health ministry, Xinhua News Agency reported.

A recommended treatment plan was released on Monday to guide  people showing mild COVID-19 symptoms or who are asymptomatic carriers, according to a report by Cambodian media. 

Under the regimen, infected adults or children of age 6 or above should take Bromhexine or Cetirizine, two other recommended medicines, or Lianhua Qingwen capsules in cases of nasal obstruction, runny nose or cough. 

It said four capsules should be taken three times a day.

A report in the Khmer Times said Lianhua Qingwen capsules have been used in several designated hospitals treating COVID-19 patients in Cambodia. 

The combined application of a COVID-19 vaccine and TCM's Lianhua Qingwen capsules has played an important role in curtailing the COVID-19 pandemic, Cambodia's health minister, Mam Bunheng, said in an interview with the Khmer Times.

"COVID-19 patients have seen improvement after taking Lianhua Qingwen capsules, which help hold off the onset of severe symptoms," he was quoted as saying.

According to Yiling Pharmaceutical, producer of the capsules in Shijiazhuang, Hebei province, the medicine has been approved and registered in more than 20 countries and regions worldwide, including Canada, Russia, Singapore, the Philippines and Kenya.